Sector: Drone-industrie
Sector: Health & Care sector
Sector: Technologie- en servicessector
Sector: Creatieve en innovatieve business
Sector: Smart energy
Sector: Circulaire economie
Sector: Land- en tuinbouw
Rejuvenate Biomed
Rejuvenate Biomed is an independent Belgian biomedical company established in October 2017 by Ann Beliën, PhD, after nearly two decades of experience with Janssen Pharmaceutical companies of Johnson & Johnson. The company is developing safe, proprietary, combination drugs that delay or prevent the onset of multiple age-related diseases, with a focus on the intersection between fundamental aging mechanisms and chronic conditions.
